New York State Common Retirement Fund Rallybio Corp Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.34 - $2.98 $13,668 - $30,396	-10,200 Reduced 97.45%	267 $0
Q4 2023 Feb 01, 2024	SELL	$1.91 - $4.39 $126 - $289	-66 Reduced 0.63%	10,467 $25,000
Q3 2023 Nov 07, 2023	BUY	$3.37 - $6.16 $566 - $1,034	168 Added 1.62%	10,533 $35,000
Q1 2023 May 02, 2023	BUY	$4.37 - $8.75 $96 - $192	22 Added 0.21%	10,365 $59,000
Q4 2022 Jan 30, 2023	BUY	$4.67 - $14.86 $28 - $89	6 Added 0.06%	10,343 $68,000
Q3 2022 Nov 08, 2022	SELL	$7.54 - $14.56 $19,211 - $37,098	-2,548 Reduced 19.77%	10,337 $150,000
Q2 2022 Aug 04, 2022	BUY	$6.26 - $13.65 $52,684 - $114,878	8,416 Added 188.32%	12,885 $97,000
Q4 2021 Feb 02, 2022	BUY	$9.3 - $19.91 $678 - $1,453	73 Added 1.66%	4,469 $43,000
Q3 2021 Nov 02, 2021	BUY	$10.83 - $23.4 $47,608 - $102,866	4,396 New	4,396 $77,000

31.9M

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $31.8M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.